HYPERA S A/S (OTCMKTS:HYPMY) and United-Guardian (NASDAQ:UG) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, institutional ownership and risk.
Earnings and Valuation
This table compares HYPERA S A/S and United-Guardian’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|HYPERA S A/S||$538.51 million||9.39||$302.21 million||N/A||N/A|
|United-Guardian||$12.97 million||6.20||$3.84 million||N/A||N/A|
This is a breakdown of recent ratings for HYPERA S A/S and United-Guardian, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|HYPERA S A/S||0||0||0||0||N/A|
Volatility & Risk
HYPERA S A/S has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, United-Guardian has a beta of -0.17, indicating that its share price is 117% less volatile than the S&P 500.
Institutional and Insider Ownership
0.2% of HYPERA S A/S shares are owned by institutional investors. Comparatively, 24.6% of United-Guardian shares are owned by institutional investors. 30.8% of United-Guardian shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
HYPERA S A/S pays an annual dividend of $0.26 per share and has a dividend yield of 3.3%. United-Guardian pays an annual dividend of $1.00 per share and has a dividend yield of 5.7%.
This table compares HYPERA S A/S and United-Guardian’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|HYPERA S A/S||31.62%||13.69%||10.97%|
United-Guardian beats HYPERA S A/S on 6 of the 11 factors compared between the two stocks.
About HYPERA S A/S
Hypera S.A. operates as a pharmaceutical company in Brazil. The company offers prescription medications under the Farmasa, Neo Química, and Luper brands; and over-the-counter medications comprising laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant, and other drugs under Gelol, Anapyon, Biotônico Fontoura, Epocler, Merthiolate, Tamarine, and Rinosoro brands. It also provides similars and generics under the Neo Química brand; dermocosmetics under the Lanidrant, Agecare, Dersab, Epidac, Epidrat, Episol, Hidramamy, Creme rejuvenecedor, Blancy, and Pielus brands; and food supplements and sweeteners. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. The company was founded in 2001 and is headquartered in São Paulo, Brazil.
United-Guardian, Inc. manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products, and specialty industrial products in the United States and internationally. It offers personal care products, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL II XD; ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics; LUBRASLIDE and B-122 powdered lubricants for use in the manufacture of pressed powders, eyeliners, and rouges; KLENSOFT, a surfactant for use in shampoos, shower gels, makeup removers, and other cosmetic formulations; and LUBRASIL, a special form of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base. The company's medical products comprise LUBRAJEL RR and RC lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC, LUBRAJEL FA, and LUBRAJEL BA, which are LUBRAJEL formulations for oral use; LUBRAJEL FLUID to lubricate water-soluble products; and LUBRAJEL TF, a medical lubricant. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder. The company's industrial products include DESELEX liquid, a sequestering and chelating agent for use in the manufacture of detergents; and THOROCLENS, a chlorine-based cleanser. United-Guardian, Inc. also conducts research and product development, primarily related to the development of cosmetic and personal care products. The company markets its products through marketing partners and distributors, advertising in medical and trade journals, mailings to physicians and to the trade, and exhibitions at medical meetings. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
Receive News & Ratings for HYPERA S A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HYPERA S A/S and related companies with MarketBeat.com's FREE daily email newsletter.